These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24301060)

  • 1. Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.
    Degrolard-Courcet E; Sokolowska J; Padeano MM; Guiu S; Bronner M; Chery C; Coron F; Lepage C; Chapusot C; Loustalot C; Jouve JL; Hatem C; Ferrant E; Martin L; Coutant C; Baurand A; Couillault G; Delignette A; El Chehadeh S; Lizard S; Arnould L; Fumoleau P; Callier P; Mugneret F; Philippe C; Frebourg T; Jonveaux P; Faivre L
    Eur J Hum Genet; 2014 Aug; 22(8):979-87. PubMed ID: 24301060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnostics.
    Bakker JL; Thirthagiri E; van Mil SE; Adank MA; Ikeda H; Verheul HM; Meijers-Heijboer H; de Winter JP; Sharan SK; Waisfisz Q
    Hum Mutat; 2014 Apr; 35(4):442-6. PubMed ID: 24395671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
    Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
    Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic FANCD1/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications.
    Dodgshun AJ; Sexton-Oates A; Saffery R; Sullivan MJ
    Cancer Genet; 2016; 209(1-2):53-6. PubMed ID: 26740091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.
    Alter BP; Rosenberg PS; Brody LC
    J Med Genet; 2007 Jan; 44(1):1-9. PubMed ID: 16825431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
    Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A
    Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.
    Radulovic I; Schündeln MM; Müller L; Ptok J; Honisch E; Niederacher D; Wiek C; Scheckenbach K; Leblanc T; Larcher L; Soulier J; Reinhardt D; Schaal H; Andreassen PR; Hanenberg H
    Hum Mol Genet; 2023 May; 32(11):1836-1849. PubMed ID: 36721989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
    Doss CG; Nagasundaram N
    Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic inactivation of BRCA2 in Fanconi anemia.
    Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
    Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Fanconi anemia lymphoid cell lines of non-A, C, D2, E, F, G subtypes for defects in BRCA2/FANCD1.
    Popp H; Kalb R; Fischer A; Lobitz S; Kokemohr I; Hanenberg H; Schindler D
    Cytogenet Genome Res; 2003; 103(1-2):54-7. PubMed ID: 15004464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
    Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
    Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoblastoma in a 4-year-old girl with Fanconi anaemia.
    Kopic S; Eirich K; Schuster B; Hanenberg H; Varon-Mateeva R; Rittinger O; Schimpl G; Schindler D; Jones N
    Acta Paediatr; 2011 May; 100(5):780-3. PubMed ID: 21138478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
    Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
    Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
    Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
    Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia.
    Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H
    Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
    Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL
    Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
    Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E
    Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.